---
schema_version: "secwatch.filing_event.v1"
accession: "0001824293-24-000052"
form_type: "8-K"
ticker: "GRI"
cik: "0001824293"
company_name: "GRI Bio, Inc."
filed_at: "2024-05-20T23:59:59+00:00"
generated_at: "2026-06-01T13:13:29.088388+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# GRI Bio enters into ATM equity offering agreement with H.C. Wainwright for up to $961,579

## Summary
- Company may sell up to $961,579 of common stock through H.C. Wainwright as sales agent.
- Wainwright receives 3% commission on gross proceeds; no obligation for Company to sell.
- Shares offered on Nasdaq as at-the-market sales under May 20, 2024 prospectus supplement.
- Company can suspend or terminate the agreement at any time; $10M aggregate cap also applies.

## SEC filing metadata
- accession: 0001824293-24-000052
- form_type: 8-K
- ticker: GRI
- cik: 0001824293
- company_name: GRI Bio, Inc.
- filed_at: 2024-05-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1824293/000182429324000052/0001824293-24-000052-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1824293/000182429324000052/val-20240520.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001824293-24-000052
- JSON: https://secwatch.observer/filing/0001824293-24-000052.json
- Plain text: https://secwatch.observer/filing/0001824293-24-000052.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.